Abstract
The epididymal lumen is an immunologically distinct environment. It maintains tolerance for the naturally antigenic spermatozoa to allow their maturation into functional cells while simultaneously defending against pathogens that can ascend the male tract and cause infertility. We previously demonstrated that a nonpathological amyloid matrix that includes several cystatin-related epididymal spermatogenic (CRES) subgroup family members is distributed throughout the mouse epididymal lumen but its function was unknown. Here, we reveal a role for the epididymal amyloid matrix in host defense and demonstrate that the CRES amyloids and CD-1 mouse epididymal amyloid matrix exhibit potent antimicrobial activity against bacterial strains that commonly cause epididymal infections in men. We show the CRES and epididymal amyloids use several defense mechanisms including bacterial trapping, disruption of bacterial membranes and promotion of unique bacterial ghost-like structures. Remarkably, these antimicrobial actions varied depending on the bacterial strain indicating CRES amyloids and the epididymal amyloids elicit strain-specific host defense responses. We also demonstrate that the CRES monomer and immature assemblies of the epididymal amyloid transitioned into advanced structures in the presence of bacteria, suggesting their amyloid-forming/shape-shifting properties allows for a rapid reaction to a pathogen and provides an inherent plasticity in their host defense response. Together, our studies reveal new mechanistic insight into how the male reproductive tract defends against pathogens. Future studies using a mouse model for human epididymitis are needed to establish the epididymal amyloid responses to pathogens in vivo. Broadly, our studies provide an example of why nature has maintained the amyloid fold throughout evolution.
Keywords: amyloid, epididymis, reproductive tract, host defense, cystatin, CRES, bacterial ghost, E. coli, epididymitis
Introduction
The epididymis is a highly convoluted tubule through which spermatozoa must pass after leaving the testis to acquire their functions of progressive motility and the ability to fertilize an oocyte. Since spermatozoa are synthetically inactive, their maturation process requires interacting with proteins and other molecules secreted into the lumen by the surrounding epididymal epithelium. In addition to maturation, the epididymis must also protect the spermatozoa, and the developing germ cells in the testis, from pathogens that can ascend the male tract and cause transient or permanent infertility. Because spermatogenesis occurs after self-tolerance has been established, spermatozoa are naturally antigenic (Wheeler et al., 2011; Tung et al., 2017). Therefore, the epididymal lumen is an immunologically distinct compartment that maintains a tolerant environment for spermatozoa to mature into functional cells. The epididymal lumen must also have the ability to mount a robust host defense response against pathogens that might access the male tract. Toward this end, the epididymis relies heavily on the innate immune system and its antimicrobial peptides (AMPs) and proteins for host defense. For example, the rodent and human epididymal epithelium secretes multiple β-defensins, SPAG11 (HE2) and its isoforms, cathelicidin (hCAP18, mouse CAMP) and other AMPs into the lumen (Malm et al., 2000; Yenugu et al., 2003; Hall et al., 2007; Yenugu and Narmadha, 2010). The epididymis also secretes several antimicrobial proteins including the secretory leukoprotease inhibitor (SLPI), lactoferrin, lysozyme, epididymal protease inhibitor (EPPIN), lipocalin-2 and others (Jin et al., 1997; Hall et al., 2002; Yenugu et al., 2004; Jenssen and Hancock, 2009; Silva et al., 2012). Despite their critical roles in protecting the germline, mechanisms by which the epididymal AMPs and proteins defend against pathogens remain poorly understood.
We previously demonstrated that a constitutively produced, nonpathological amyloid matrix is present throughout the normal mouse epididymal lumen (Whelly et al., 2012, 2016). Its functional role in the epididymis has not been established. Highly ordered cross-β-sheet-rich amyloids have typically been considered as pathological entities associated with neurodegenerative diseases and prionopathies. Work from our laboratory and others have shown, however, that functional amyloid assemblies exist in species ranging from bacteria to humans. These biological amyloids carry out a broad range of functions including acting as biological scaffolds, storage depots, protective barriers and signaling complexes (Fowler et al., 2007; Pham et al., 2014; Hewetson et al., 2017) (reviews). The epididymal amyloid matrix includes several members of the reproductive cystatin-related epididymal spermatogenic (CRES) subgroup of family 2 cystatins of cysteine protease inhibitors. CRES subgroup members CRES (Cst8), CRES2 (Cst11), CRES3 (Cst12), cystatin E2 and the ubiquitously expressed, prototypical family 2 cystatin, cystatin C (Cst3), colocalize within the epididymal amyloid matrix, suggesting coordinated functions (Whelly et al., 2016). In addition, CRES has lost its cysteine protease inhibitory activity, but subgroup members maintain robust amyloidogenic/shape-shifting functions (Cornwall et al., 2003; Whelly et al., 2016). CRES and CRES2 are expressed in the human epididymis but whether they assemble into a functional amyloid has not been determined (Hamil et al., 2002; Wassler et al., 2002). Recombinant cystatin C (human) and CRES subgroup members CRES (mouse), CRES2 (human) and testatin (Cst9, human) have also been shown to exhibit antimicrobial activity in vitro and may represent a new family of antimicrobial proteins (Hamil et al., 2002; Wang et al., 2012; Eaves-Pyles et al., 2013; Holloway et al., 2018). Whether their antimicrobial activities require an amyloid structure is not known.
Here, we present results showing a biological role for the mouse epididymal amyloid matrix in host defense. CRES amyloids and the epididymal amyloid matrix use multiple mechanisms, including bacterial trapping and membrane disruption, to protect against pathogens that commonly cause human epididymal infections. In addition to these classic responses, CRES amyloid and the epididymal amyloids also promoted the formation of unique bacterial ghost-like structures, not previously described in the epididymis or known to be in response to amyloid. We also show that CRES monomer and immature epididymal amyloid formed advanced amyloid structures in the presence of bacteria to enable their antimicrobial actions, a response similar to other host defense amyloids. However, CRES and the epididymal amyloid matrix are distinct as they formed different amyloid structures and elicited different host defense responses (trapping versus killing) depending upon the pathogen. Together our studies show the epididymal amyloid matrix is a multidimensional antimicrobial amyloid that uses its unique shape-shifting properties to protect the host via several mechanisms.
Materials and methods
Isolation of epididymal amyloids
All animal studies were conducted in accordance with the NIH Guidelines for the Care and Use of Experimental Animals using protocol # 94041 approved by the Texas Tech University Health Sciences Center Institutional Animal Care and Use Committee. Male CD1 mice (22–28 weeks of age) were obtained from Charles River (Wilmington, MA, USA) and maintained under a constant 12 h light/12 h dark cycle with food and water ad libitum. Nestlets were provided for nesting. Two mice were used for each experiment and were euthanized by CO2 asphyxiation followed by cervical dislocation. The luminal contents from the caput and corpus-cauda epididymis were isolated by puncturing the tissue in Dulbecco’s PBS (dPBS) using a 30G needle and allowing material to disperse for 15 min at room temperature. The samples were centrifuged at 500g for 5 min to remove spermatozoa (pellet 1: P1). The S1 supernatant was spun again to remove any remaining spermatozoa and then centrifuged at 5000g for 10 min to generate pellet 2 (P2). The resulting supernatant (S2) was centrifuged at 15 000g for 10 min to generate pellet 3 (P3) followed by centrifugation of the S3 supernatant at 250 000g for 70 min using a table-top Beckman ultracentrifuge to generate the final S4 supernatant (SUP) and P4 pellet (P4). All pellets were resuspended in dPBS and proteins quantified by BCA assay (ThermoScientific, Rockford, IL, USA).
Expression, purification and assembly of CRESC48A protein into amyloid
Tag-less full-length mouse CRESC48A protein was expressed and purified as described previously using affinity, ion exchange and gel filtration chromatography (Do et al., 2019). Immediately after elution off the gel filtration column, CRESC48A was buffer exchanged into 25 mM MES, pH 6 using a 10 kDa Amicon-Ultra-15 filter (Millipore, Burlington, MA, USA). Briefly, ∼2.5 mg of protein in 20–30 ml was combined and spun in a 10-kDa Amicon-Ultra filter (14 ml at a time) (Millipore) at 2550g, 4°C, in a swinging bucket rotor until 1 ml of protein remained. The protein was moved to a new 10 kDa Amicon-Ultra-15 filter and 13 ml of 25 mM MES, pH 6.0, was added. The protein was spun at 2550g until 1 ml remained. Another 13 ml of 25 mM MES, pH 6.0, was added to the protein in the filter unit, the sample gently mixed by pipetting and 1 ml removed as the CRESC48A monomer (0.14–0.19 mg/ml concentration). The remaining protein was centrifuged at 2550g until 1 ml remained (∼2 mg/ml final concentration). The protein was moved to a 1.5 ml microcentrifuge tube and 250 μl was removed as ‘Early Amyloid’. Then, 250 μl 50 mM HEPES, pH 8.0, was added to the ∼750 µl of remaining protein (the amount of 50 mM HEPES, pH 8, added is ¼ the final volume) and the sample was spun in a 10 kDa Amicon-Ultra filter (0.5 ml) at 16 100g, 4°C in a microcentrifuge until 100 μl remained. The filter was inverted in a new tube and spun at 1000g for 2 min to elute protein off the filter. An aliquot (50 µl) was removed as ‘Intermediate Amyloid’ and typically was ∼12–14 mg/ml, pH 6.8. Monomer, Early Amyloid, Intermediate Amyloid and remaining protein (∼40–50 µl) were kept at 4°C overnight. The next morning, the remaining protein was sonicated at 3 × 30 pulses at 20% duty, 1 × 30 pulses at 30% duty and 1 × 30 pulses at 50% duty using a Heat Systems Ultrasonic sonicator (Qsonica, Newtown, CT, USA) and the resulting suspension (∼12–14 mg/ml) was the ‘Advanced Amyloid’. Protein concentrations were determined using a Nanodrop Lite spectrophotometer (ThermoScientific, Rockford, IL, USA). The CRESC48A monomer and different amyloid preparations were used immediately.
Colony-forming unit assay
The pathogenic Escherichia coli strain UI012 was a generous gift from Abdul Hamood, Ph.D., Texas Tech University Health Sciences Center, who obtained the clinical isolate under an Institutional Review Board approved protocol. The commensal E. coli strain MM294 was also a gift from A. Hamood and obtained from the American Type Culture Collection (Manassas, VA, USA). E. coli were grown overnight (16 hr) in Luria–Bertani (LB) broth at 37°C with shaking at 180 rpm. The overnight culture was used to start a log phase growth and bacteria were grown for 2 hr to OD600 0.5. One milliliter of the log phase bacteria was centrifuged at 9000g for 5 min and resuspended in 1 ml dPBS, pH 6.8 (Sigma Chemical Co, St. Louis, MO, USA) to wash bacteria free of LB. The spin was repeated twice and the final pellet was resuspended in dPBS to an OD600 0.5 ± 0.03. Bacteria were serially diluted 1:10 in dPBS, pH 6.8 and 20 μl log−3 bacteria were added to 20 μl CRESC48A monomer and amyloids (final concentration 0.5–20 µg/ml) and 85 μl dPBS, pH 6.8 (assay buffer, final volume 125 μl) in a low protein binding 96-well plate (Costar 7007, Corning, Corning, NY, USA). Incubations were carried out for 2 hr at 37°C with shaking at 150 rpm. The reactions were diluted 1:10 in dPBS, pH 6.8, and 25 μl plated onto LB agar plates for overnight growth at 37°C. The number of colony-forming units (CFUs) was determined by manual counting of colonies. The percentage survival was calculated by comparing the CFUs in the presence of protein/CFUs in control (bacteria incubated in buffer only). The number of bacterial CFUs used in each assay was determined by plating log−5 to log−6 dilutions of each bacterial culture on LB agar plates followed by manual counting of colonies the next day. The average number ± SEM of bacterial CFUs for E. coli MM294 was 4833 ± 806 and E. coli UI012, 2343 ± 156. The same protocol was used for CFU assays with the epididymal amyloids except that 25 mM HEPES, pH 6.8 was used in place of dPBS throughout the assay. The average number ± SEM of bacterial CFUs for E. coli MM294 was 2895 ± 708, and E. coli UI012, 1418 ± 85.
Live-dead assay
Bacterial strains were prepared as described in the CFU assay. Twenty microliters of log−2 bacteria were incubated with 20 μl of 5–30µg/ml protein and 85 μl of 25 mM HEPES, pH 6.8 (assay buffer) in a low protein binding 96-well plate. Five microliters of 500 μg/ml DAPI (20 μg/ml final) and 5 μl 125 μg/ml propidium iodide (PI: 5 μg/ml final) were added to the samples and incubated at room temperature in the dark for 20 min. The samples were centrifuged at 12 200g in a swinging bucket rotor for 45 min and the majority of the supernatant removed. The remaining ∼10 μl was used to resuspend the bacteria and 4 μl were spotted on to a slide, a coverslip added, and images immediately captured using a Zeiss Axiovert 200M microscope equipped with epifluorescence (Zeiss, Okerkochen, Germany). The percentage of bacteria with intact membranes was calculated by the number of healthy bacteria/the total number of bacteria counted × 100. Ghosts were not included in the percentages calculated for bacteria with intact membranes.
Negative stain transmission electron microscopy
Twenty microliters of log−2 bacteria were incubated with 20 μl of 20 µg/ml protein and 85 μl of dPBS, pH 6.8, or 25 mM HEPES, pH 6.8 (assay buffer) in a low protein binding 96-well plate (Costar, Kennebunk, ME, USA). Incubations were carried out for 2 hr at 37°C with shaking at 150 rpm. The samples were centrifuged twice at 12 200g in a swinging bucket for 15 min and majority of the supernatant was removed. For transmission electron microscopy (TEM), 5 μl of the reactions were spotted on to Formvar/carbon-coated 200 mesh nickel grids (Ted Pella, Redding, CA, USA) and allowed to dry. The sample was washed for 1 min with water, stained with 1% uranyl acetate for 1 min, washed twice with water for 1 min and dried for 2 min. Grids were examined with a Hitachi 7650 electron microscope (Hitachi High-Tech America, Schaumburg, IL, USA).
Bacterial trapping/immunofluorescence
E. coli strain MM294 was grown overnight (16 hr) in LB at 37°C with shaking at 180 rpm. The overnight culture was used to start a log phase growth and bacteria were grown for 2 hr to OD600 0.5. One milliliter of the log phase bacteria was centrifuged at 9000g for 5 min and resuspended in 150 μl of 20 μg/ml of DAPI. Bacteria were incubated at room temperature in the dark for 20 min. Then, bacteria were spun at 9000g for 5 min, resuspended in 1 ml dPBS to remove remaining DAPI, spun again and resuspended in dPBS to OD600 0.5 ± 0.03. Twenty microliters of log−1 bacteria were incubated with 20 μl of 20 µg/ml (final) protein and 85 μl of 25 mM HEPES (assay buffer) in a low protein binding 96-well plate. Incubations were carried out for 15 min at 37°C with shaking at 150 rpm. Samples were fixed for 15 min by adding formaldehyde (4% final) to each well. Samples were spun at 12 200g in a swinging bucket rotor for 15 min and the majority of the supernatant was removed. The bacteria were resuspended in the remaining volume (∼10 µl) and 5 μl of each reaction was spread on a slide (∼1 cm × 1 cm square) and dried overnight. Slides were rehydrated in dPBS for 2 min and then blocked in 100% heat-inactivated goat serum (HIGS) (Vector Laboratories, Newark, CA, USA) for 1 hr at room temperature followed by incubation with rabbit anti-oligomeric amyloid A11 antiserum (1:1500) (Millipore, Billeria, MA, USA), rabbit anti-fibrillar amyloid OC antiserum (1:1500) (Millipore), or normal rabbit serum (1:1500) (ThermoScientific) in 20% HIGS/dPBS overnight at 4°C. Slides were washed in dPBS 5× 2 min each, followed by incubation with a goat anti-rabbit Alexafluor 594 secondary antibody (1:1000) (Invitrogen) in 20% HIGS/dPBS at room temperature in the dark for 2 hr. Slides were washed in dPBS 5× 2 min each, in H2O 1× 2 min, and mounted with Vectamount (Vector Laboratories). Images were captured on a Zeiss Axiovert 200M microscope equipped with epifluorescence.
Dynamic light scattering
CRESC48A freshly eluted off the gel filtration column at concentrations ranging from 0.17 to 0.24 mg/ml was examined by dynamic light scattering (DLS) within 2 hr of elution using a Zetasizer Nano ZS (Red) (ZEN3600, Malvern Instrument) equipped with a 633-nm red laser and 173° scattering angle, as described previously (Do et al., 2019). Other samples were examined after buffer exchange to remove NaCl and following transition to amyloid, as described above.
Thioflavin T assay
The amyloid content of CRESC48A monomer and different maturational states of amyloid were determined by thioflavin T (ThT) fluorescence. Briefly, 15 μg of each sample in 12.5 mM MES, 18.5 mM HEPES, pH 6.8, was added to a 96-well black flat-bottom plate (Corning, NY, USA) and ThT added to 20 μM final in a final volume of 100 μl. Fluorescence was measured using a TECAN Infinite M1000 PRO microplate reader (Tecan Group Ltd, Männedorf, Switzerland) in the fluorescence top reading mode. The excitation and emission wavelengths were 440 nm ± 5 and 485 nm ± 10, respectively. ThT fluorescence was determined by averaging at least 10 reads and subtracting the ThT blank (all assay components except protein).
Statistics
Statistical analyses were performed by ANOVA followed by a Tukey or Dunnett’s post-test using Graphpad Prism 9.3.1 software (GraphPad Software, San Diego, CA, USA). All data are presented as mean ± SEM unless indicated otherwise.
Results
CRES amyloid assembly in vitro
We used CRES as a model for the epididymal amyloid matrix to determine if its monomer and/or amyloid forms have antimicrobial activity. To prevent inappropriate disulfide bond formation during protein expression, we modified the cysteine at position 48 in CRES to alanine (CRESC48A). Full-length mouse CRESC48A was purified under nondenaturing conditions from the soluble fraction of bacteria as we described previously (Do et al., 2019). Upon gel filtration, CRESC48A eluted primarily as a monomer (particle diameter of 4.9 ± 0.7 nm) (Fig. 1A) with also a second population of larger particles (400–800 nm) present, indicative of its propensity to aggregate (Do et al., 2019). We next exchanged the monomer into 25 mM MES, pH 6, buffer. DLS and TEM showed CRESC48A had an average particle size of 4.3 ± 0.4 nm diameter and little higher ordered structure indicating it was still primarily monomeric (Fig. 1C and D). To induce amyloid assembly, CRESC48A in 25 mM MES, pH 6 was concentrated to ∼2 mg/ml. In addition to monomer (average diameter 5.0 ± 0.5 nm), we observed granular sheets and small assemblies of branched matrix by TEM suggesting changes in CRESC48A that corresponded with early amyloid structures (Fig. 1C and D). Further adjustments of the sample to pH 6.8 (characteristic of the intraluminal pH in the caput epididymis) and concentration to ∼12 mg/ml caused the monomer to shift to a larger particle (6.3 ± 0.6 nm diameter), which we determined previously is a metastable oligomer (Do et al., 2019). Particles with a larger diameter (∼1000 nm) were also detected in this sample that correlated with the appearance of larger patches of branched amyloid matrix and fragments of film (Fig. 1C and D). This sample was defined as intermediate amyloid. Finally, the sample was sonicated briefly yielding a CRESC48A population that lacked monomer/oligomer and contained a highly branched amyloid matrix that structurally mimicked that which is found in the mouse caput epididymal lumen (Do et al., 2019). The sonicated sample was defined as advanced amyloid (Fig. 1C and D). Using X-ray diffraction we demonstrated previously that the advanced CRESC48A amyloid exhibits cross-β-sheet architecture characteristic of amyloid (Do et al., 2019). ThT (a fluorescent dye that exhibits a spectral shift upon binding to amyloid; Biancalana and Koide, 2010) staining of the different CRESC48A assemblies confirmed the presence of increased β-sheet structure in the advanced amyloid sample compared to that in monomer and early/intermediate amyloids (P < 0.0001) (Fig. 1B).
Figure 1.
In vitro assembly of mouse CRESC48A amyloid. (A) Dynamic light scattering (DLS) analysis of cystatin-related epididymal spermatogenic (CRES)C48A freshly eluted off the gel filtration column. Intensity measurements showed populations of CRES particles at 4–8 and 400–5000 nm. Inset, an average hydrodynamic radius for the particles between 4 and 8 nm was calculated from the fitted data and diameter ± SD is reported for n = 4 CRESC48A preparations. Owing to large variations in particle size, we were unable to fit the CRES particles between 400 and 5000 nm. (B) Thioflavin T (ThT) analysis of amyloid content in monomer, early, intermediate, and advanced CRESC48A amyloid preparations. *P < 0.001 comparing advanced CRESC48A amyloids to monomer, early, and intermediate amyloids as determined by ANOVA followed by Tukey post-test. RFU: relative fluorescence units. (C) Negative stain transmission electron microscopy and (D) DLS analysis of CRESC48A monomer and different amyloid assemblies. Scale bar, 0.5 µm.
Amyloid forms of CRESC48A have antimicrobial activity
The monomer and different maturational states of CRESC48A amyloid were tested for antimicrobial activity in a CFU assay against commensal (MM294) and uropathogenic (UI012) strains of E. coli, the most common cause of human epididymal infections (Michel et al., 2015). The number of CFUs tested was consistent with bacteria present in human infections and in mouse models of epididymitis (Michel et al., 2016). As shown in Fig. 2A, after 2 hr incubation, the intermediate and advanced CRESC48A amyloids resulted in a dose-dependent decrease in the percentage of pathogenic E. coli UI012 that survived compared to bacteria incubated in buffer alone (control, black bars). This effect was not seen with monomeric or early amyloid forms of CRESC48A. In contrast, the survival of a commensal strain of E. coli MM294 was minimally affected by CRESC48A (Fig. 2B). Our results show that CRESC48A exhibits antimicrobial activity that is associated with its higher ordered amyloid forms. Further, our previous studies showing that similar preparations of advanced CRESC48A amyloids did not decrease the viability of mouse epididymal cells in culture (Do et al., 2019) suggest the amyloids specifically affect bacteria and not mammalian host cells.
Figure 2.
Mouse CRESC48A amyloids decrease pathogenic E. coli survival. Colony-forming unit (CFU) assays show the percentage of (A) pathogenic Escherichia coli UI012 and (B) commensal E. coli MM294 that survived following a 2 hr incubation with increasing concentrations (0.5–20 μg/ml) of cystatin-related epididymal spermatogenic (CRES)C48A monomer and amyloids. C, Control samples of bacteria incubated in buffer only. Buffer for monomer and early amyloid was 25 mM MES, pH 6. Buffer for intermediate and advanced amyloid was 18.75 mM MES, 12.5 mM HEPES, pH 6.8. The number of CFUs in the control samples was set to 100%. Values shown are the mean ± SEM of 6–8 replicate experiments using 6–8 different CRESC48A preparations. *P < 0.0001–0.0117 compared to control as determined by ANOVA followed by Tukey post-test.
CRESC48A amyloids trap bacteria and disrupt bacterial membranes
To elucidate the mechanism(s) resulting in the reduced bacterial survival (Fig. 2), we first determined if the CRESC48A amyloids can trap bacteria. Commensal and pathogenic E. coli were stained with DAPI and then incubated with intermediate and advanced CRESC48A amyloids followed by staining with the anti-amyloid antibodies A11 and OC in immunofluorescence analysis. As shown in Fig. 3A, both commensal E. coli MM294 and pathogenic E. coli UI012 bacteria (blue speckles) were trapped by the A11- and OC- labeled CRESC48A amyloids (red fluorescence) forming large inclusions. The positive staining with both anti-A11 (oligomeric amyloid) and anti-OC (fibrillar amyloid) suggests several populations of CRESC48A amyloids are present in the resulting structures. Bacteria incubated in the absence of CRESC48A amyloid were free floating and not agglutinated (Fig. 3A). These results suggest that one host defense function of the CRESC48A amyloid is the physical trapping of bacteria.
Figure 3.
Antimicrobial mechanisms of the mouse CRESC48A amyloids. (A) Escherichia coli MM294 and UI012 were labeled with DAPI and incubated with intermediate and advanced cystatin-related epididymal spermatogenic (CRES)C48A amyloids for 15 min. Samples were spread on a slide and incubated with the anti-amyloid antibodies A11 and OC or normal rabbit serum (NRS, negative control) in immunofluorescence analysis. The merged images of DAPI (blue) and Alexa 594 (red) fluorescence reveal bacteria are trapped by CRESC48A amyloid. Scale bar all images, 0.2 µm. (B) Advanced CRESC48A amyloids were incubated with 104 CFUs E. coli MM294 and E. coli UI012 for 15 min and 2 hr after which the samples were examined by negative stain transmission electron microscopy. Scale bar, 0.5 µm. G, Bacterial ghost-like structure. (C–F) Live/dead assays were performed following incubation of bacteria with increasing concentrations (0.5–20 μg/ml) of CRESC48A monomer and amyloids and the percentage of bacteria with intact membranes and ghost-like structures are shown. C, Control bacteria incubated in buffer only. Buffer for monomer and early amyloid was 25 mM MES, pH 6. Buffer for intermediate and advanced amyloid was 18.75 mM MES, 12.5 mM HEPES, pH 6.8. The number of bacteria with intact membranes in the control samples was set to 100%. Representative DAPI and propidium iodide staining patterns of healthy, membrane damaged, and ghost-like structures are shown in Supplementary Fig. S1. Values shown are the mean ± SEM of three replicate experiments using three different CRESC48A preparations. *P < 0.0001–0.0103 compared to control as determined by ANOVA followed by Dunnetts post-test.
We used negative stain TEM to examine further the interactions between the advanced CRESC48A amyloid and the two E. coli strains. After only 15 min, the advanced CRESC48A amyloid matrix had attached to both strains of bacteria (Fig. 3B). The pathogenic E. coli UI012 were particularly affected by the CRESC48A amyloid matrix, since after 2 hr the trapped cells often appeared distorted with ruffled membranes or, for some, only structures characteristic of bacterial ghosts remained (Fig. 3B) (Hjelm et al., 2015). Ghosts are nonliving empty envelopes of gram-negative bacteria that have extruded their cytoplasm and DNA but still retain a functional cell membrane that can activate a broad range of immune cells (Langemann et al., 2010). The advanced amyloid matrix also trapped the commensal E. coli MM294 and ghost-like structures were also occasionally detected (Fig. 3B). Our results imply that, in addition to trapping, the advanced CRESC48A amyloid may kill some bacterial strains.
We next used a live/dead assay to quantify the number of bacteria that had damaged membranes and to distinguish this population from those that had formed ghost-like structures following incubation with CRESC48A monomer and amyloids. E. coli MM294 and E. coli UI012 were stained with DAPI (membrane permeable) and PI (membrane impermeable) and cells were imaged and counted using fluorescence microscopy. Representative staining patterns of the bacteria are shown in Supplementary Fig. S1. Bacteria with disrupted membranes were DAPI positive/PI positive (faint or strong). Bacterial ghost-like structures were identified by their faint DAPI staining, often at the cell periphery, and no PI fluorescence or strong DAPI stained dense bodies at their septum or poles, and no PI fluorescence (Supplementary Fig. S1). The intermediate and advanced CRESC48A amyloids, but not the monomeric or early amyloids, reduced the percentage of pathogenic E. coli UI012 that had intact membranes suggesting CRESC48A is bactericidal against this strain (Fig. 3C). Although not as profound as observed with E. coli UI012, E. coli MM294 also showed decreased membrane integrity in the presence of intermediate and advanced amyloids (Fig. 3E). This outcome was different from the CFU assay in which no change in E. coli MM294 bacterial survival was noted across all CRESC48A populations (Fig. 2B). Because more E. coli (104) were needed to perform the live/dead assay, a more pronounced response from CRESC48A may have occurred. We also cannot rule out the possibility that membrane integrity was reduced due to a fast exponential growth of these cells (Berney et al., 2007). A small percentage of pathogenic and commensal E.coli formed ghost-like structures in the presence of CRESC48A amyloid (Fig. 3D and F) However, only the pathogenic E. coli UI012 showed a significant increase in the percentage of ghost-like structures compared to control (buffer only) bacteria (Fig. 3D).
Commensal and pathogenic bacteria induce changes in CRESC48A structure
Some antimicrobial proteins assemble into amyloid only after their interaction with bacteria, as a means to trap or trap and kill the pathogen (Brinkmann et al., 2004; Chu et al., 2012). To determine if bacteria induce changes in CRESC48A, monomer was incubated with commensal and pathogenic E. coli and structural changes were monitored by TEM after 15 min and 2 hr. In the absence of bacteria, the few visible structures in the CRESC48A monomer in buffer alone (control) exhibited minimal change over the time course (Fig. 4A, B, C and D). The addition of bacteria, however, caused a profound change in CRESC48A monomer that varied with the bacterial strains and time. Following 15 min incubation with the commensal E. coli MM294, film fragments were detected in the CRESC48A monomer that often extended fibrils to the bacterial surface (Fig. 4E and F). In contrast, after 2 hr, assemblies of branched matrix were prevalent and included populations that were attached to and trapped the bacteria (Fig. 4G and H). Incubation of CRESC48A monomer with the pathogenic E. coli UI012 similarly resulted in the appearance of film fragments (Fig. 4I and K); however, broad arrays of fibrils were associated with the bacterial surface while little to no matrix was present (Fig. 4J and L). Further, ghost-like structures were common and often had fibrils associated with their surface (Fig. 4J and L). Our studies suggest the commensal and pathogenic E. coli promoted aggregation in a strain-dependent manner with CRESC48A assembling into its characteristic branched matrix (Do et al., 2019) in the presence of commensal E. coli but forming fibrils with the pathogenic E. coli. Although none of the amyloid structures were present in samples of bacteria incubated in buffer alone we cannot eliminate the possibility that some assemblies were generated by the bacteria in response to CRESC48A as bacteria also use amyloid as a host defense mechanism (Schwartz and Boles, 2013).
Figure 4.
Changes in mouse CRESC48A monomer in the presence of bacteria. Cystatin-related epididymal spermatogenic (CRES)C48A (20 μg/ml) monomer was incubated with 104 bacteria for 15 min and 2 hr, samples were pelleted and then dried on to Formvar/carbon-coated 200 mesh nickel grids for analysis by negative stain transmission electron microscopy. G, ghost-like structure. Scale bar, 0.5 or 2 μm as indicated. Images are representative of three experiments.
The epididymal amyloid matrix has antimicrobial activity
Having shown that CRESC48A amyloids are antimicrobial (Figs 2, 3 and 4), we next wanted to determine whether the endogenous mouse epididymal amyloid matrix (which contains CRES and other CRES subgroup members) also has antimicrobial activity. As shown schematically in Fig 5A, the epididymis is a single, long, highly coiled tubule that connects the testis to the vas deferens and which functionally matures and protects the spermatozoa as they migrate from the proximal/caput to the distal/cauda part of the tubule. CRES, CRES2, CRES3 and cystatin E2 are synthesized by the epithelium in the caput epididymis and secreted into the lumen where they are components of the assembling amyloid matrix (Whelly et al., 2016). The amyloid matrix changes along the length of the epididymal tubule, transitioning from a highly branched structure in the caput epididymis to mostly fibrillar in the corpus-cauda epididymis (Supplementary Fig. S2). We used differential centrifugation to isolate the epididymal amyloids (pellet fractions P2, P4) from the caput and corpus-cauda epididymal lumen (Fig. 5B and Supplementary Fig. S2). Previously, in addition to using anti-amyloid antibodies (A11, OC), we used conformation-dependent dyes Thioflavin S and Congo Red and X-ray diffraction to demonstrate that the caput and corpus-cauda P2 and P4 pellet fractions contain cross-β-sheet-rich amyloids (Whelly et al., 2012, 2016).
Figure 5.
The mouse epididymal amyloid-containing fractions decrease Escherichia coli survival. (A) Schematic diagram of the rodent epididymis showing the caput and corpus-cauda regions and its connections to the testis and vas deferens. Scale bar, 3 mm. (B) Differential centrifugation protocol used to isolate amyloids of different molecular mass from the caput and corpus-cauda epididymal lumen. S, supernatant; P, pellet. The P3 pellet contained little thioflavin S positive material and was not studied further. Colony-forming unit (CFU) assays show the percentage of (C) E. coli MM294 and (D) E. coli UI012 that survived following a 2 hr incubation with increasing concentrations (1–30 μg/ml) of the P2 and P4 amyloid fractions and final supernatant (SUP, S4) fraction from the caput and corpus-cauda epididymis. C: control, bacteria incubated in buffer only. The number of CFUs in the control samples was set to 100%. Values shown are the mean ± SEM of 4–6 replicate experiments using 4–6 different epididymal amyloid preparations. *P < 0.0001–0.0128 compared to control as determined by ANOVA followed by Tukey post-test.
To determine if the epididymal amyloids have antimicrobial activity along the length of the epididymal tubule, the P2 and P4 amyloid-containing fractions from the caput and corpus-cauda epididymis were incubated with the two bacterial strains and CFU assays were performed as described for CRESC48A amyloids. The P2 and P4 fractions from the caput and corpus-cauda caused a dose-dependent decrease in the survival of the commensal (Fig. 5C) and pathogenic strain of E. coli (Fig. 5D), with a more robust effect observed against the commensal strain. Together, our results show that the endogenous amyloids (P2 and P4 fractions) from the caput and cauda epididymis have antimicrobial activity but that their effectiveness varies depending on the bacterial strain. We cannot rule out that other structures such as extracellular vesicles/exosomes (EVs) that may pellet with the epididymal amyloids contribute to the antimicrobial activity. Indeed, we have shown previously that populations of CRES subgroup members are associated with EVs (Whelly et al., 2016). The final supernatant (SUP, S4), resulting from the high-speed centrifugation to generate pellet 4 (Fig. 5B) and representing the soluble fraction from the caput and corpus-cauda, also exhibited robust antimicrobial activity against the E. coli strains. This activity likely reflects the antimicrobial actions of other AMPs that are present in the epididymal lumen such as defensins (Hall et al., 2007) and/or soluble oligomeric forms of antimicrobial amyloids.
Caput and corpus-cauda epididymal amyloids trap bacteria and undergo structural changes
To determine a mechanism for the antimicrobial activity of the epididymal amyloids against the E. coli strains, we first used TEM to examine their interactions. Similar interactions/structures were noted after 15 min and 2 hr coincubation and therefore only the 2 hr time points are shown. Epididymal amyloid from the caput and corpus-cauda P2 and P4 fractions attached to and surrounded the bacteria suggesting that, like CRESC48A, one host defense response is to trap the bacteria (Fig. 6). Further, the epididymal amyloids often underwent structural changes in the presence of bacteria. Specifically, spherical structures that are prevalent in the caput and corpus-cauda P2 fractions and that may be early condensates/assemblies (Fig. 6A, C, E and G and Supplementary Fig. S2), coalesced and transitioned into dense matrices that surrounded and trapped the commensal E. coli MM294 (Fig. 6B and D). A similar coalescence of spheres occurred in the presence of E. coli UI012. However, compared to the commensal strain, the assemblies were smaller and ghost-like structures were frequently observed (Fig. 6F and H).
Figure 6.
Host defense responses of the caput and corpus-cauda epididymal amyloids. Pellet 2 and pellet 4 (P2, P4) and final supernatant (SUP, S4) fractions (20 µg/ml) from the mouse caput and corpus-cauda epididymis were incubated with 104Escherichia coli MM294 and E. coli UI012 for 2 hr, after which samples were pelleted and dried onto grids for analysis by negative stain transmission electron microscopy. Epididymal amyloids incubated in buffer only served as controls. Scale bar, 0.5 or 2 μm as indicated. G, bacterial ghost-like structure. Based on DAPI stained images in Supplementary Fig. S1, we speculate the dense body associated with the bacterium in panel V is extruded DNA/cytosol. Images are representative of two experiments.
The highly branched matrix and films typical of caput P4 amyloid (Supplementary Fig. S2), became a thin matrix/film after dilution in the assay buffer (control), suggesting some disassembly (Fig. 6I and M). However, following the addition of E. coli MM294, dense matrices and thick films that trapped bacteria were observed (Fig. 6J). In contrast, matrix was rarely detected following incubation of caput P4 amyloid with E. coli UI012 but bacteria were often ghost-like (Fig. 6N). In the corpus-cauda epididymis, the thin fibrils and matrix typical of the P4 amyloid (Supplementary Fig. S2) trapped both commensal and pathogenic E.coli in thin film-like webs and occasionally in fibrillar matrices (Fig. 6L and P); however, ghost-like structures were more often detected in the pathogenic E. coli UI012 samples (Fig. 6P).
The supernatants (SUP, S4), which represent the soluble fraction of the epididymal fluid, contained few structures except for individual spheres, which may be very early condensates, small particles and the occasional thin or branched matrix (Fig. 6Q, S, U and W and Supplementary Fig. S2). Commensal and pathogenic E. coli incubated with the caput and corpus-cauda SUP appeared intact (Fig. 6T), or were observed transitioning into (Fig. 6V), or had already formed ghost-like structures (Fig. 6R and X). The ghost-like structures were detected more often in the pathogenic E. coli UI012 compared to the commensal strain. Together, our TEM results show the epididymal amyloids undergo structural changes in the presence of bacteria, often forming more advanced assemblies (spheres to matrix, increased matrix) that trap the pathogen. The structures that formed, however, varied between the commensal and pathogenic E. coli strains. It is possible that local disassembly of the epididymal amyloids may also occur in response to bacteria.
Epididymal amyloids disrupt E. coli membranes and promote ghost-like structures
As performed with CRESC48A, we used the live/dead assay to quantify the number of bacteria that had disrupted membranes and those that had formed ghost-like structures following incubation with the epididymal amyloids. As shown in Fig. 7A, all epididymal amyloid-containing fractions caused a significant decrease in the percentage of pathogenic E. coli UI012 that had intact membranes compared to control bacteria incubated in buffer alone. In contrast, only the highest concentrations of caput P2 and P4 amyloid fractions were effective at disrupting the bacterial membranes of the commensal E. coli MM294 while the other epididymal amyloid populations showed little effect (Fig. 7C). In addition, ghost-like structures were prevalent in E. coli UI012 after incubation with the epididymal amyloid populations, especially in the P4 amyloid and soluble/supernatant fractions (Fig. 7B), confirming our results by TEM (Fig. 6). In contrast, fewer ghost-like structures were detected in the commensal E. coli MM294 (Fig. 7D).
Figure 7.
Mouse epididymal amyloid-containing fractions disrupt Escherichia coli membranes and promote bacterial ghost-like structures in a strain-dependent manner. Live/dead assays were performed to determine bacterial membrane integrity and the induction of bacterial ghost-like structures following a 2 hr incubation of (A and B) E. coli UI012 and (C and D) E. coli MM294 with increasing concentrations (0.5–30 μg/ml) of the pellet 2 (P2) and P4 amyloid fractions and final supernatant (SUP, S4) from the caput and corpus-cauda epididymis. Representative DAPI and propidium iodide staining patterns of healthy, membrane damaged, and ghost-like structures are shown in Supplementary Fig. S1. Values represent mean ± SEM of 3–5 replicate experiments. C, control samples of bacteria incubated in buffer only; T, bacteria incubated in 1% Triton X-100 (positive control). *P < 0.0001–0.0483 compared to control as determined by ANOVA followed by Dunnetts post-test.
Discussion
Host defense functions of the epididymal amyloid matrix
Our studies reveal a functional role for the epididymal amyloid matrix in host defense. We show that the different epididymal amyloid-containing fractions and CRESC48A amyloids exhibit potent antimicrobial activity against commensal and pathogenic strains of E. coli, the most common causes of epididymal infections in men (Pilatz et al., 2015). Epididymitis is usually caused by the ascent of bacteria in the urogenital tract, with pathogens originating from urinary tract infections or sexually transmitted diseases (Michel et al., 2015). In addition to E. coli, other common pathogens that cause epididymal infections are Chlamydia trachomatis and Neisseria gonorrhoeae but also can include Pseudomonas aeruginosa, Staphylococcus aureus and others (Michel et al., 2015).
Our studies show the epididymal amyloids and CRESC48A amyloids use several antimicrobial mechanisms to protect the host. Both the P2 and P4 epididymal amyloid fractions and the advanced CRESC48A amyloids, represented by an amyloid matrix, rapidly attached to and surrounded the bacteria suggesting that trapping is an initial and perhaps primary mode of defense. Furthermore, CRESC48A monomer and P2 amyloids transitioned into matrix in the presence of bacteria indicating bacterial membranes may function as biological templates to facilitate the assembly of immature amyloids into functional structures to enable trapping. This is not unlike several other antimicrobial amyloids such as the α-defensin HD6 in the gut that assembles into nanonets only after encountering the pathogen (Chu et al., 2012). Whether the P2 structures represent early maturational states of amyloid that will ultimately assemble into matrix or fibrils or are structures that normally exist in equilibrium with the advanced amyloid forms within the epididymal lumen is not known. The caput P4 amyloid, and to a lesser degree the corpus-cauda P4 amyloid, also underwent structural transitions in the presence of bacteria to facilitate trapping although the changes observed varied depending on the pathogen.
The epididymal amyloid-containing fractions and CRESC48A amyloids also disrupt bacterial membranes (Figs 3 and 7). In particular, pathogenic E. coli were affected more than the commensal strain suggesting CRESC48A and the epididymal amyloids elicit different responses depending upon the strain of bacteria or pathogen. The trapping of bacteria by the epididymal amyloids involved multiple points of association with the membrane that could lead to a generalized disruption. The promotion of ghost-like structures (Figs 6 and 7), however, is likely the result of membrane damage by a different mechanism as these cells remained impervious to PI, a membrane impermeable dye (Fig. 7 and Supplementary Fig. S1). Ghosts have been observed in gram-negative bacteria after their infection with bacteriophage ΦΧ174 and are caused by the expression of a phage lysis protein that oligomerizes to form a single lysis tunnel in the bacterial membrane (Witte and Lubitz, 1989). Our studies show that mammalian amyloids promote structures that resemble bacterial ghosts. We have not determined if the inner and outer membranes fused to form a lysis tunnel in the ghost-like bacteria that we observed and thus cannot conclude that they are ghosts. However, the ghost-like structures exhibited DNA positive dense bodies at potential cell division sites (center or poles) on the bacterial surface, sites where DNA and cytosol are extruded and hallmarks of lysis tunnel formation (Fig. 6V and Supplementary Fig S1) (Witte et al., 1992). Together, our data indicate that the bactericidal properties of CRESC48A and the epididymal amyloids are likely a result of several different mechanisms that may be determined by the maturational state of the amyloid as well as the pathogen they encounter.
The strain-specific host defense responses of the epididymal and CRESC48A amyloids mimic human infections
Human epididymitis induced by different pathogenic bacterial infections has different characteristics. Infection with pathogenic strains of E. coli often results in luminal occlusions while infection with commensal strains of E. coli do not, suggesting distinct host defense responses within the human epididymal lumen (Michel et al., 2016). Indeed, up to 40% of men who have recovered from an infection with a pathogenic E. coli strain still exhibit oligospermia and infertility, possibly owing to sperm obstruction as a result of the epididymal occlusion. Similar E. coli strain-specific phenotypes have been recapitulated in a mouse model for human epididymitis (Lang et al., 2013). The mechanisms that underlie these pathogen-specific responses, including the events that lead to the formation of luminal occlusions, are not well understood. Our studies show that CRESC48A amyloid and the epididymal amyloids responded differently to the commensal and pathogenic E. coli stains in vitro suggesting the same may occur within the epididymal lumen and possibly contribute to the diverse characteristics of human epididymal infections. Collectively our data show the epididymal amyloids and CRESC48A assembled into dense matrices that trapped but minimally killed the commensal E. coli MM294. In contrast, fewer assemblies surrounded the pathogenic E. coli UI012 but bactericidal activity was significant and included the prevalence of ghost-like structures (summarized in Supplementary Table SI). Because bacterial ghosts are highly immunogenic, they may activate distinct and robust innate and adaptive immune responses, such as toll-like receptors and downstream proinflammatory responses, which are not, or only minimally activated, with the commensal strain, leading to inclusions within the epididymal lumen. In our studies, the bacterial ghost-like structures were especially numerous in epididymal amyloid and supernatant fractions from the corpus-cauda epididymis as compared to the caput, indicating that host defense responses within the epididymis may vary between regions. Our observations are consistent with what happens in human epididymal infections wherein the cauda elicits a stronger immune response and inflammatory damage compared to the caput region (Pleuger et al., 2020). Future studies using a mouse model for epididymitis will help establish the contributions of the epididymal amyloid matrix to these pathogen- and region-specific phenotypes.
The transition of CRESC48A monomer and immature epididymal amyloids to advanced assemblies following exposure to the bacteria may be a reaction to specific virulence factors the bacteria release and/or components associated with their surface/membrane. E. coli and other gram-negative strains possess lipopolysaccharide in their membranes, a toxin that can activate host immune responses including inducing some AMPs to assemble into amyloid (Wang et al., 2014). Other proteins and peptides assemble into amyloid directly from their interactions with membrane lipids (Soria et al., 2017; Gu and Guo, 2021). Gram-negative and some gram-positive bacteria possess pili and fimbrae that function in cell migration and adhesion but which are also virulence factors and in some bacteria are amyloids that can interact with mammalian amyloidogenic AMPs (Kai-Larsen et al., 2010). The contributions of one or several of these bacterial factors could lead to the structural changes in CRESC48A and the epididymal amyloids.
A new host defense amyloid
Our studies showing the epididymal amyloid matrix is a host defense structure broadens the list of antimicrobial amyloids that exist in nature to include a sophisticated amyloid scaffold that functions to protect the male germline (Kagan et al., 2012). We show the epididymal amyloid matrix is exquisitely sensitive to pathogens, adopting different conformations and using distinct host defense mechanisms depending on the bacterial strain that is present. Whether strain-specific host defense responses are unique to the epididymal amyloid matrix or also a characteristic of other host defense amyloids is not known. However, the presence of CRES and other amyloidogenic CRES subgroup family members within the epididymal amyloid matrix may contribute to its fluidity. Indeed, our studies here show that CRES carries out its antimicrobial functions as an amyloid, forming distinct structures and eliciting strain-specific effects on bacteria, similar to that of the endogenous amyloid matrix. In previous studies, we determined that CRES can assemble into amyloid via several different pathways (Hewetson et al., 2020), which could be influenced by the local environment, such as bacterial virulence factors, and allow different conformations/functions. While we have yet to establish if other CRES subgroup members also exhibit antimicrobial activity as amyloids, their presence within the amyloid matrix could allow the formation of distinct β-sheet assemblies further contributing to a robust and plastic antimicrobial structure. Based on our observations, we speculate the maturational state of the epididymal amyloid matrix (caput versus corpus-cauda, P2 versus P4 amyloids), the pathogen it encounters and its repertoire of secreted and surface-associated virulence factors, and possibly local pathogen load, may influence the host defense response. As we show with CRES48A monomer and the epididymal amyloids, a response was often the transition of immature structures into more advanced forms (matrix, films and fibrils). However, it is also possible that the epididymal amyloids disassemble to generate soluble oligomeric conformers that could create tunnels or pores in bacterial membranes, potentially promoting bacterial ghosts (Di Scala et al., 2016).
It is of interest that other AMPs and proteins in the epididymal lumen are also prone to aggregation. These include the LL-37 peptide of cathelicidin hCAP-18 (mouse CAMP), a potent AMP that self-assembles into helical fibrils structurally similar to the cross-α amyloids of the S. aureus phenol soluble modulin PSMα3 peptide (Engelberg and Landau, 2020), lactoferrin (Nilsson and Dobson, 2003) and lysozyme (Booth et al., 1997). The β-sheet-rich defensins also may also form amyloid for their antimicrobial actions, similar to some α-defensins such as HD6 (Chu et al., 2012). Thus, while some AMPs in the epididymal lumen are soluble, as indicated by the antimicrobial activity in the supernatant fractions, it is possible that other aggregation-prone epididymal AMPs contribute to the assembly of, or are attached to, the epididymal amyloid matrix possibly via cross-α and cross-β-sheet interactions. Such a highly integrated scaffold could further expand the potential for distinct assemblies to form as needed in order to respond to a diverse repertoire of pathogens and also provide a means to coordinate multiple host defense responses following an infection, including the activation of downstream immune responses.
Finally, because the epididymal amyloid matrix is constitutively expressed and dispersed throughout the lumen intertwined with the maturing spermatozoa, we think it likely it also carries out critical roles in sperm maturation. Several epididymal AMPs and proteins, including β-defensins, lactoferrin, EPPIN, lysozyme and lysozyme-like protein 6, SPAG11 isoforms and others, have dual functions. In addition to their antimicrobial roles, they bind to spermatozoa and affect their function, including fertilizing ability, in both rodent models and humans (Jin et al., 1997; Yenugu et al., 2004; Zhou et al., 2004; Wei et al., 2013; Huang et al., 2017). Similarly, cathelicidin, CRES, CRES2 and CRES3 bind to epididymal spermatozoa for reasons not yet known (Malm et al., 2000; Cornwall, unpublished observations). Perhaps by integrating multifunctional AMPs, antimicrobial proteins and possibly other proteins into a common yet sophisticated amyloid scaffold the epididymis has devised a way to integrate its two critical functions of sperm maturation and protection.
Supplementary Material
Acknowledgements
The authors gratefully acknowledge Abdul Hamood, Ph.D., TTUHSC for his generous sharing of bacterial isolates and helpful comments and suggestions and Stephany Navarro, M.S., TTUHSC for her assistance with the CFU and biofilm assays. The authors also thank Jannette Dufour, Ph.D., Clint MacDonald, Ph.D., and R. Bryan Sutton, Ph.D. TTUHSC for their critical reading of the article.
Authors’ roles
C.M. and G.A.C. designed the experiments, C.M., M.C.H., and G.A.C. performed the experiments and analyzed the data, and C.M. and G.A.C. wrote the paper. All authors approved the final version of the article.
Funding
TTUHSC and The Newby Family (to G.A.C.). The funders had no role in the study design, data collection and interpretation or preparation and reporting of the study.
Conflict of interest
The authors declare that they have no conflicts of interest with the contents of this article.
Contributor Information
Caitlyn Myers, Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Mary Catherine Hastert, College of Arts and Sciences Microscopy, Texas Tech University, Lubbock, TX, USA.
Gail A Cornwall, Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Supplementary data
Supplementary data are available at Molecular Human Reproduction online.
Data Availability
All data are contained within the article.
References
- Berney M, Hammes F, Bosshard F, Weilenmann HU, Egli T.. Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight kit in combination with flow cytometry. Appl Environ Microbiol 2007;73:3283–3290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Biancalana M, Koide S.. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 2010;1804:1405–1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CCF. et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997;385:787–793. [DOI] [PubMed] [Google Scholar]
- Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A.. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532–1535. [DOI] [PubMed] [Google Scholar]
- Chu H, Pazgier M, Jung G, Nuccio S-P, Castillo PA, de Jong MF, Winter MG, Winter SE, Wehkamp J, Shen B. et al. Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 2012;337:477–481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cornwall GA, Cameron A, Lindberg I, Hardy DM, Cormier N, Hsia N.. The cystatin-related epididymal spermatogenic protein inhibits the serine protease prohormone convertase 2. Endocrinology 2003;144:901–908. [DOI] [PubMed] [Google Scholar]
- Di Scala C, Yahi C, Boutemeur N, Flores S, Rodriguez A, Chahinian L, Fantini H.. J. Common molecular mechanism of amyloid pore formation by Alzheimer's beta-amyloid peptide and alpha-synuclein. Sci Rep 2016;6:28781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Do HQ, Hewetson A, Myers C, Khan NH, Hastert MC, Harsini FM, Latham MP, Wylie BJ, Sutton RB, Cornwall GA.. The functional mammalian CRES (Cystatin-Related Epididymal Spermatogenic) amyloid is antiparallel beta-sheet rich and forms a metastable oligomer during assembly. Sci Rep 2019;9:9210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eaves-Pyles T, Patel J, Arigi E, Cong YZ, Cao A, Garg N, Dhiman M, Pyles RB, Arulanandam B, Miller AL. et al. Immunomodulatory and antibacterial effects of cystatin 9 against Francisella tularensis. Mol Med 2013;19:263–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Engelberg Y, Landau M.. The human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure. Nat Commun 2020;11:3894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fowler DM, Koulov AV, Balch WE, Kelly JW.. Functional amyloid—from bacteria to humans. Trends Biochem Sci 2007;32:217–224. [DOI] [PubMed] [Google Scholar]
- Gu L, Guo ZF.. Lipid membranes induce structural conversion from amyloid oligomers to fibrils. Biochem Biophys Res Commun 2021;557:122–126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hall SH, Hamil KG, French FS.. Host defense proteins of the male reproductive tract. J Androl 2002;23:585–597. [PubMed] [Google Scholar]
- Hall SH, Yenugu S, Radhakrishnan Y, Avellar MCW, Petrusz P, French FS.. Characterization and functions of beta defensins in the epididymis. Asian J Androl 2007;9:453–462. [DOI] [PubMed] [Google Scholar]
- Hamil KG, Liu Q, Sivashanmugam P, Yenugu S, Soundararajan R, Grossman G, Richardson RT, Zhang YL, O'Rand MG, Petrusz P et al Cystatin 11: a new member of the cystatin type 2 family. Endocrinology 2002;143:2787–2796. [DOI] [PubMed] [Google Scholar]
- Hewetson A, Do HQ, Myers C, Muthusubramanian A, Sutton RB, Wylie BJ, Cornwall GA.. Functional amyloids in reproduction. Biomolecules 2017;7:46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hewetson A, Khan NH, Dominguez MJ, Do HQ, Kusko RE, Borcik CG, Rigden DJ, Keegan RM, Sutton RB, Latham MP. et al. Maturation of the functional mouse CRES amyloid from globular form. Proc Natl Acad Sci U S A 2020;117:16363–16372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hjelm A, Soderstrom B, Vikstrom D, Jong WSP, Luirink J, de Gier JW.. Autotransporter-based antigen display in bacterial ghosts. Appl Environ Microbiol 2015;81:726–735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holloway AJ, Yu J, Arulanandam BP, Hoskinson SM, Eaves-Pyles T.. Cystatins 9 and C as a novel immunotherapy treatment that protects against multidrug-resistant New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2018;62:e01900–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang P, Li WS, Yang ZF, Zhang N, Xu YX, Bao JY, Jiang DK, Dong XP.. LYZL6, an acidic, bacteriolytic, human sperm-related protein, plays a role in fertilization. PLoS One 2017;12:e0171452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jenssen H, Hancock REW.. Antimicrobial properties of lactoferrin. Biochimie 2009;91:19–29. [DOI] [PubMed] [Google Scholar]
- Jin YZ, Bannai S, Dacheux F, Dacheux JL, Okamura N.. Direct evidence for the secretion of lactoferrin and its binding to sperm in the porcine epididymis. Mol Reprod Dev 1997;47:490–496. [DOI] [PubMed] [Google Scholar]
- Kagan BL, Jang H, Capone R, Arce FT, Ramachandran S, Lal R, Nussinov R.. Antimicrobial properties of amyloid peptides. Mol Pharm 2012;9:708–717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kai-Larsen Y, Luthje P, Chromek M, Peters V, Wang XD, Holm A, Kadas L, Hedlund KO, Johansson J, Chapman MR. et al. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 2010;6:e1001010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lang TL, Dechant M, Sanchez V, Wistuba J, Boiani M, Pilatz A, Stammler A, Middendorff R, Schuler G, Bhushan S. et al. Structural and functional integrity of spermatozoa is compromised as a consequence of acute uropathogenic E. coli-associated epididymitis. Biol Reprod 2013;89:59. [DOI] [PubMed] [Google Scholar]
- Langemann T, Koller V, Muhammad A, Pavol K, Ulrike B, Lubitz W.. The bacterial ghost platform system: production and applications. Bioeng Bugs 2010;1:326–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malm J, Sørensen O, Persson T, Frohm-Nilsson M, Johansson B, Bjartell A, Lilja H, Ståhle-Bäckdahl M, Borregaard N, Egesten A.. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun 2000;68:4297–4302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Michel V, Duan Y, Stoschek E, Bhushan S, Middendorff R, Young JM, Loveland KL, De Kretser DM, Hedger MP, Meinhardt A.. Uropathogenic Escherichia coli causes fibrotic remodelling of the epididymis. J Pathol 2016;240:15–24. [DOI] [PubMed] [Google Scholar]
- Michel V, Pilatz A, Hedger MP, Meinhardt A.. Epididymitis: revelations at the convergence of clinical and basic sciences. Asian J Androl 2015;17:756–763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nilsson MR, Dobson CM.. In vitro characterization of lactoferrin aggregation and amyloid formation. Biochemistry 2003;42:375–382. [DOI] [PubMed] [Google Scholar]
- Pham CLL, Kwan AH, Sunde M.. Functional amyloid: widespread in Nature, diverse in purpose. Essays Biochem 2014;56:207–219. [DOI] [PubMed] [Google Scholar]
- Pilatz A, Hossain H, Kaiser R, Mankertz A, Schuttler CG, Domann E, Schuppe HC, Chakraborty T, Weidner W, Wagenlehner F.. Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations. Eur Urol 2015;68:428–435. [DOI] [PubMed] [Google Scholar]
- Pleuger C, Silva EJR, Pilatz A, Bhushan S, Meinhardt A.. Differential immune response to infection and acute inflammation along the epididymis. Front Immunol 2020;11:599594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schwartz K, Boles BR.. Microbial amyloids—functions and interactions within the host. Curr Opin Microbiol 2013;16:93–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silva EJR, Patrao M, Tsuruta JK, O'Rand MG, Avellar MCW.. Epididymal protease inhibitor (EPPIN) is differentially expressed in the male rat reproductive tract and immunolocalized in maturing spermatozoa. Mol Reprod Dev 2012;79:832–842. [DOI] [PubMed] [Google Scholar]
- Soria MA, Cervantes SA, Bajakian TH, Siemer AB.. The functional amyloid Orb2A binds to lipid membranes. Biophys J 2017;113:37–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tung KSK, Harakal J, Qiao H, Rival C, Li JCH, Paul AGA, Wheeler K, Pramoonjago P, Grafer CM, Sun W. et al. Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance. J Clin Invest 2017;127:1046–1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang JR, Li Y, Wang XM, Chen W, Sun HB, Wang JF.. Lipopolysaccharide induces amyloid formation of antimicrobial peptide HAL-2. Biochim Biophys Acta 2014;1838:2910–2918. [DOI] [PubMed] [Google Scholar]
- Wang L, Yuan Q, Chen SH, Cai H, Lu MG, Liu Y, Xu C.. Antimicrobial activity and molecular mechanism of the CRES protein. Plos One 2012;7:e48368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wassler M, Syntin P, Sutton-Walsh HG, Hsia N, Hardy DM, Cornwall GA.. Identification and characterization of cystatin-related epididymal spermatogenic protein in human spermatozoa: Localization in the equatorial segment. Biol Reprod 2002;67:795–803. [DOI] [PubMed] [Google Scholar]
- Wei J, Li S-J, Shi H, Wang H-Y, Rong C-T, Zhu P, Jin S-H, Liu J, Li J-Y.. Characterisation of Lyzls in mice and antibacterial properties of human LYZL6. Asian J Androl 2013;15:824–830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wheeler K, Tardif S, Rival C, Luu B, Bui E, del Rio R, Teuscher C, Sparwasser T, Hardy D, Tung KSK.. Regulatory T cells control tolerogenic versus autoimmune response to sperm in vasectomy. Proc Natl Acad Sci U S A 2011;108:7511–7516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whelly S, Johnson S, Powell J, Borchardt C, Hastert MC, Cornwall GA.. Nonpathological extracellular amyloid is present during normal epididymal sperm maturation. PLoS One 2012;7:e36394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whelly S, Muthusubramanian A, Powell J, Johnson S, Hastert MC, Cornwall GA.. Cystatin-related epididymal spermatogenic subgroup members are part of an amyloid matrix and associated with extracellular vesicles in the mouse epididymal lumen. Mol Hum Reprod 2016;22:729–744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Witte A, Lubitz W.. Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli. Eur J Biochem 1989;180:393–398. [DOI] [PubMed] [Google Scholar]
- Witte A, Wanner G, Sulzner M, Lubitz W.. Dynamics of phi X174 protein E-mediated lysis of Escherichia coli. Arch Microbiol 1992;157. [DOI] [PubMed] [Google Scholar]
- Yenugu S, Hamil KG, Birse CE, Ruben SM, French FS, Hall SH.. Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli. Biochem J 2003;372:473–483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yenugu S, Narmadha G.. The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics. J Pept Sci 2010;16:337–341. [DOI] [PubMed] [Google Scholar]
- Yenugu S, Richardson RT, Sivashanmugam P, Wang ZJ, O'Rand MG, French FS, Hall SH.. Antimicrobial activity of human EPPIN, an androgen-regulated, sperm-bound protein with a whey acidic protein motif. Biol Reprod 2004;71:1484–1490. [DOI] [PubMed] [Google Scholar]
- Zhou CX, Zhang Y-L, Xiao L, Zheng M, Leung KM, Chan MY, Lo PS, Tsang LL, Wong HY, Ho LS. et al. An epididymis-specific beta-defensin is important for the initiation of sperm maturation. Nat Cell Biol 2004;6:458–464. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data are contained within the article.







